Exact Sciences (EXAS) Tops Q2 EPS by 8c, Sales Beat; Raises Cologuard Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/12/2026

1. MIRM
2. SPY
3. META
4. MSFT
5. PLTR
6. JNJ
7. HUM
8. CSCO
9. KTOS
10. NVDA

Go back to Exact Sciences (EXAS) Tops Q2 EPS by 8c, Sales Beat; Raises Cologuard Outlook

Exact Sciences (EXAS) PT Raised to $45 at Canaccord Genuity Following 2Q

July 26, 2017 10:11 AM EDT

Canaccord Genuity raised its price target on Exact Sciences (NASDAQ: EXAS) to $45.00 (from $42.00) while maintaining a Buy rating. 2Q revenues of $57.6M came in ahead of the Street's $49.7M. EXAS holds $483M of cash and Cologuard is now covered by 235M... More